These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
308 related articles for article (PubMed ID: 30102653)
41. Maraviroc Is Associated with Latent HIV-1 Reactivation through NF-κB Activation in Resting CD4 Madrid-Elena N; García-Bermejo ML; Serrano-Villar S; Díaz-de Santiago A; Sastre B; Gutiérrez C; Dronda F; Coronel Díaz M; Domínguez E; López-Huertas MR; Hernández-Novoa B; Moreno S J Virol; 2018 May; 92(9):. PubMed ID: 29444937 [TBL] [Abstract][Full Text] [Related]
42. Bronchoalveolar CD4+ T cell responses to respiratory antigens are impaired in HIV-infected adults. Jambo KC; Sepako E; Fullerton DG; Mzinza D; Glennie S; Wright AK; Heyderman RS; Gordon SB Thorax; 2011 May; 66(5):375-82. PubMed ID: 21357587 [TBL] [Abstract][Full Text] [Related]
43. Dynamics of pulmonary mucosal cytotoxic CD8 T-cells in people living with HIV under suppressive antiretroviral therapy. Alexandrova Y; Yero A; Olivenstein R; Orlova M; Schurr E; Estaquier J; Costiniuk CT; Jenabian MA Respir Res; 2024 Jun; 25(1):240. PubMed ID: 38867225 [TBL] [Abstract][Full Text] [Related]
44. Pre-ART HIV-1 DNA in CD4+ T cells correlates with baseline viro-immunological status and outcome in patients under first-line ART. Ceccherini-Silberstein F; Cozzi Lepri A; Alteri C; Merlini E; Surdo M; Marchetti G; Capobianchi MR; De Luca A; Gianotti N; Viale P; Andreoni M; Antinori A; Perno CF; d'Arminio Monforte A; J Antimicrob Chemother; 2018 Dec; 73(12):3460-3470. PubMed ID: 30247724 [TBL] [Abstract][Full Text] [Related]
45. Plasma Indoleamine 2,3-Dioxygenase Activity Is Associated With the Size of the Human Immunodeficiency Virus Reservoir in Patients Receiving Antiretroviral Therapy. Chen J; Xun J; Yang J; Ji Y; Liu L; Qi T; Wang Z; Zhang R; Shen Y; Ponte R; Mehraj V; Routy JP; Lu H Clin Infect Dis; 2019 Apr; 68(8):1274-1281. PubMed ID: 30107503 [TBL] [Abstract][Full Text] [Related]
46. Phospholipid Metabolism Is Associated with Time to HIV Rebound upon Treatment Interruption. Giron LB; Papasavvas E; Yin X; Goldman AR; Tang HY; Palmer CS; Landay AL; Li JZ; Koethe JR; Mounzer K; Kostman JR; Liu Q; Montaner LJ; Abdel-Mohsen M mBio; 2021 Feb; 12(1):. PubMed ID: 33622719 [TBL] [Abstract][Full Text] [Related]
47. Relationship between CD38 expression on peripheral blood T-cells and monocytes, and response to antiretroviral therapy: a one-year longitudinal study of a cohort of chronically infected ART-naive HIV-1+ patients. Almeida M; Cordero M; Almeida J; Orfao A Cytometry B Clin Cytom; 2007 Jan; 72(1):22-33. PubMed ID: 17051525 [TBL] [Abstract][Full Text] [Related]
48. Changes in levels of T cell subpopulations to monitor the response to antiretroviral therapy among HIV-1-infected patients during two years of HIV-1 replication suppression. Zhang JC; Zhang HJ; Li Y; Jing D; Liu Q; Zhao K; Liu QQ; Zhuang Y; Kang WZ; Sun YT Scand J Infect Dis; 2013 May; 45(5):368-77. PubMed ID: 23186319 [TBL] [Abstract][Full Text] [Related]
49. CD32 Expression is not Associated to HIV-DNA content in CD4 cell subsets of individuals with Different Levels of HIV Control. García M; Navarrete-Muñoz MA; Ligos JM; Cabello A; Restrepo C; López-Bernaldo JC; de la Hera FJ; Barros C; Montoya M; Fernández-Guerrero M; Estrada V; Górgolas M; Benito JM; Rallón N Sci Rep; 2018 Oct; 8(1):15541. PubMed ID: 30341387 [TBL] [Abstract][Full Text] [Related]
50. HIV Persistence in Adipose Tissue Reservoirs. Couturier J; Lewis DE Curr HIV/AIDS Rep; 2018 Feb; 15(1):60-71. PubMed ID: 29423731 [TBL] [Abstract][Full Text] [Related]
51. Episomal HIV-1 DNA and its relationship to other markers of HIV-1 persistence. Martinez-Picado J; Zurakowski R; Buzón MJ; Stevenson M Retrovirology; 2018 Jan; 15(1):15. PubMed ID: 29378611 [TBL] [Abstract][Full Text] [Related]
52. Quantification of Residual Germinal Center Activity and HIV-1 DNA and RNA Levels Using Fine Needle Biopsies of Lymph Nodes During Antiretroviral Therapy. Hey-Nguyen WJ; Xu Y; Pearson CF; Bailey M; Suzuki K; Tantau R; Obeid S; Milner B; Field A; Carr A; Bloch M; Cooper DA; Kelleher AD; Zaunders JJ; Koelsch KK AIDS Res Hum Retroviruses; 2017 Jul; 33(7):648-657. PubMed ID: 28287825 [TBL] [Abstract][Full Text] [Related]
53. Elevated CD57 and CD95 expressions are associated with lower numbers of CD4⁺ recent thymic emigrants in HIV-1 infected immune responders following antiretroviral treatment. Lu I; Eberhard J; Ahmad F; Bhatnagar N; Behrens G; Jacobs R; Schmidt RE; Meyer-Olson D Immunol Lett; 2014; 158(1-2):1-6. PubMed ID: 24291117 [TBL] [Abstract][Full Text] [Related]
54. HIV-1 transcriptional activity during frequent longitudinal sampling in aviremic patients on antiretroviral therapy. Leth S; Nymann R; Jørgensen S; Olesen R; Rasmussen TA; Østergaard L; Denton PW; Tolstrup M; Søgaard OS AIDS; 2016 Mar; 30(5):713-21. PubMed ID: 26595541 [TBL] [Abstract][Full Text] [Related]
55. HIV reservoir dynamics in HAART-treated poor immunological responder patients under IL-7 therapy. Logerot S; Rancez M; Charmeteau-de Muylder B; Figueiredo-Morgado S; Rozlan S; Tambussi G; Beq S; Couëdel-Courteille A; Cheynier R AIDS; 2018 Mar; 32(6):715-720. PubMed ID: 29369157 [TBL] [Abstract][Full Text] [Related]
56. Both CD31(+) and CD31⁻ naive CD4(+) T cells are persistent HIV type 1-infected reservoirs in individuals receiving antiretroviral therapy. Wightman F; Solomon A; Khoury G; Green JA; Gray L; Gorry PR; Ho YS; Saksena NK; Hoy J; Crowe SM; Cameron PU; Lewin SR J Infect Dis; 2010 Dec; 202(11):1738-48. PubMed ID: 20979453 [TBL] [Abstract][Full Text] [Related]
57. Distribution and reduction magnitude of HIV-DNA burden in CD4+ T cell subsets depend on art initiation timing. Gantner P; Barnig C; Partisani M; Lee GQ; Beck-Wirth G; Faller JP; Martinot M; Mosheni-Zadeh M; Cheneau C; Batard ML; Fischer P; Fuchs A; Uring-Lambert B; Bahram S; Rey D; Fafi-Kremer S AIDS; 2018 Apr; 32(7):921-926. PubMed ID: 29424775 [TBL] [Abstract][Full Text] [Related]
58. Comprehensive Mass Cytometry Analysis of Cell Cycle, Activation, and Coinhibitory Receptors Expression in CD4 T Cells from Healthy and HIV-Infected Individuals. Corneau A; Cosma A; Even S; Katlama C; Le Grand R; Frachet V; Blanc C; Autran B Cytometry B Clin Cytom; 2017 Jan; 92(1):21-32. PubMed ID: 27997758 [TBL] [Abstract][Full Text] [Related]
59. Naive and Memory CD4⁺ T Cells Are Differentially Affected in Indonesian HIV Patients Responding to ART. Tanaskovic S; Fernandez S; Saraswati H; Yunihastuti E; Gani RA; Djauzi S; Price P Viral Immunol; 2016 Apr; 29(3):176-83. PubMed ID: 27035638 [TBL] [Abstract][Full Text] [Related]
60. Recovery of effective HIV-specific CD4+ T-cell activity following antiretroviral therapy in paediatric infection requires sustained suppression of viraemia. Adland E; Mori L; Laker L; Csala A; Muenchhoff M; Swordy A; Mori M; Matthews P; Tudor-Williams G; Jooste P; Goulder P AIDS; 2018 Jul; 32(11):1413-1422. PubMed ID: 29734220 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]